Using a high‐throughput kinase activity mapping platform, Ruiz‐Saenz A et al identified that Proto‐oncogene tyrosine‐protein kinase (SRC) kinases are systematically activated in BRAF(V600E) CRC following targeted inhibition of BRAF and EGFR. This evidence concerns the gene SRC and colorectal carcinoma.